Skip to main content

Whitepapers

Filter

The Journey of a Small Molecule: From First Hit to Market

Discover how small-molecule drug development often stalls not due to scientific limitations, but due to…

FAIR Data in Biopharma: An Excelra Perspective

Biopharma R&D produces vast, complex datasets that often slow innovation. This whitepaper explores how FAIR…
Data-Readiness-for-AI

Data Readiness for AI in Pharma and Biotech

Excelra’s whitepaper explores how pharma and biotech companies can achieve data readiness to accelerate AI…
BioVisualizer-Enhancing-biological-data-analysis

BioVisualizer™: Enhancing biological data analysis and interpretation

The rapid pace at which biological and preclinical  data is generated presents challenges in management,…

Accelerating in-vitro antibody discovery with artificial intelligence

Antibodies are a relatively new treatment class that has shown great promise for the treatment…

Smoothing the path to drug development with accurate preclinical data

Understanding how a drug behaves in the body is critical to its success. This whitepaper…
ai-ml-medical-imaging

Power of AI/ML in Medical Imaging: Role in Cancer Diagnosis & treatment

Contributors: Shipra Gupta, Tanusree Chaudhuri, Praveen Korepu, Nag Himakund Mallampalli, Lingaraju Halasiddappa, Uzma Saeed, Jitesh…

Omics Data: A Biomedical Asset Driving The Future Of Drug Discovery And Development

Data has become one of the most valuable assets for modern-day drug discovery. Data along…

Transforming Unstructured Data into Actionable Insights Using AI

In today’s rapidly advancing life sciences landscape, researchers are constantly challenged by overwhelming amounts of…